Organization | Swedish Institute for Infectious Disease Control

Swedish Institute for Infectious Disease Control Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4

Founded: Solna Sweden (2014)

Organization Overview

First Clinical Trial

None

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2012

Timeline

NOW

Now

Alternative names

Swedish Institute of Infectious Disease Control

Active Ingredients

Drugs in Phase 4 Trials (1)

acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (1 trial)

Drugs in Phase 3 Trials (2)

inactivated japanese encephalitis vaccine (Ixiaro) (1 trial)

japanese encephalitis virus vaccine, suspension of infected mouse brain (1 trial)

Drugs in Phase 2 Trials (5)

cyclophosphamide (cytoxan) (1 trial)

hivis dna vaccine (1 trial)

modified vaccinia ankara hiv vaccine (1 trial)

mva-cmdr (1 trial)

sargramostim (leukine) (1 trial)

Drugs in Phase 1 Trials (2)

bpze1 (1 trial)

hiv dna vaccine (1 trial)

Drugs in Other Trials (1)

e. coli 83972 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Colorectal Neoplasms (Phase 2)

Diphtheria (Phase 4)

Encephalitis (Phase 3)

Encephalitis, Japanese (Phase 3)

Tetanus (Phase 4)

Tetany (Phase 4)

Whooping Cough (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 11